Showing results (371-380 of 378) with videos related to
Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 378 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2000
Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetesA Fard, C H Tuck, J A Donis, et al.Atherosclerosis|September 23, 1997
Phenotype expression in familial combined hyperlipidemiaK V Porkka, I Nuotio, P Pajukanta, et al.Lancet (London, England)|November 29, 2005
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialA Keech, R J Simes, P Barter, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 22, 2017
Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese menN Matikainen, S Söderlund, E Björnson, et al.The Journal of Clinical Investigation|February 15, 1997
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defectM Lehto, T Tuomi, M M Mahtani, et al.Lancet (London, England)|November 9, 2007
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialA C Keech, P Mitchell, P A Summanen, et al.Journal of Internal Medicine|May 27, 2017
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesityM-R Taskinen, S Söderlund, L H Bogl, et al.Journal of Internal Medicine|April 11, 2017
Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetesM I Lassenius, C L Fogarty, M Blaut, et al.Pageof 38